This book stems from the urgent necessity to address neurodegenerative diseases, which are among the most severe health challenges currently confronting society. Neurodegenerative diseases have become a major threat to public health in recent years, impacting millions of people globally and creating a substantial strain on healthcare systems and society as a whole. Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis are examples of these diseases. This book offers a thorough survey of the latest developments in this rapidly growing field. This book is targeted towards a wide range of readers, including academics, researchers, medical professionals, students, policy makers, and anybody else who is interested in the convergence of neuroscience, nanotechnology, and healthcare. Irrespective of one’s familiarity with the subject, this book provides motivation and insightful information to bolster our group’s endeavors in combating these debilitating diseases.
With no approved drug for Autism, this book presents a novel approach validated by brain imaging and large clinical trials. It details a repurposed drug’s unprecedented potential to be the first pediatric treatment, describing specific cases of children who improved.
